Jagsonpal Pharmaceuticals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Jagsonpal Pharmaceuticals Limited has informed stock exchanges that it has obtained a certificate under SEBI's Depositories and Participants Regulations, 2018. This regulatory compliance document confirms that the company's shares are properly held in electronic form with a Depository Participant. It serves as a formal attestation of the company's adherence to the regulatory framework governing shareholding and dematerialization.

This development is a routine administrative update for the company. For investors, it primarily signals that Jagsonpal Pharmaceuticals is maintaining proper corporate governance standards and ensuring the integrity of its shareholding structure. It does not indicate any immediate financial change or operational shift.

Investors should view this as a standard compliance filing. There is no new information provided regarding the company's business performance or financial results. Market participants should continue to focus on the company's operational metrics and broader market trends for investment decisions.